Biogen (BIIB)

R&D to Revenue

18.11%

Quarterly · Period ending:

BIIB logo

BIIB R&D to Revenue

Latest reported18.11%
BIIB Quarterly R&D/Revenue (0.00% → 18.11%)
High-resolution chart · PNG

BIIB r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D to Revenue — Quarterly
Period endingR&D to Revenue
18.114%
23.1254%
22.3446%
15.0562%
20.0302%
22.4558%
27.8445%
27.2934%
24.0294%
22.864%
27.1341%
31.5061%
25.9406%
25.205%
30.5267%
24.1459%
23.0234%
24.4332%
28.0781%
29.2706%
43.5027%
22.7283%
69.2456%
36.24%
19.2606%
17.6216%
18.8407%
15.0107%
13.4045%
16.1528%
17.344%
15.5685%
31.4613%
16.1828%
17.7684%
14.5039%
29.7622%
15.0639%
18.5898%
17.897%
16.3465%
16.0371%
19.0786%
18.7156%
18.9342%
18.0242%
18.9373%
16.6109%
18.4713%
24.8331%
22.0736%
22.4325%
19.0145%
20.0933%
27.4258%
21.9563%
23.1928%
27.5509%
25.547%
28.8837%
23.6334%
24.4015%
3.7626%
44.5704%
27.3501%
31.2939%
25.1169%
27.1352%
38.0918%
26.964%
27.3892%
24.5937%
25.3924%
27.4078%
25.668%
36.2725%
28.2147%
26.742%
-516.9572%
29.9979%
24.5417%
23.8707%
-221.3842%
38.0803%
29.695%
29.3427%
-677.481%
30.98%
31.5133%
29.335%
-236.5199%
28.3931%
40.5796%
27.2163%
30.1561%
36.2611%
33.1824%
28.6003%
29.8701%
29.75%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.